Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013

Detalles Bibliográficos
Autores principales: Eyckmans, Tom, Wollants, Elke, Janssens, Ann, Schoemans, Hélène, Lagrou, Katrien, Wauters, Joost, Maertens, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2014
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012818/
https://www.ncbi.nlm.nih.gov/pubmed/24751368
http://dx.doi.org/10.3201/eid2005.131766
_version_ 1782314977633239040
author Eyckmans, Tom
Wollants, Elke
Janssens, Ann
Schoemans, Hélène
Lagrou, Katrien
Wauters, Joost
Maertens, Johan
author_facet Eyckmans, Tom
Wollants, Elke
Janssens, Ann
Schoemans, Hélène
Lagrou, Katrien
Wauters, Joost
Maertens, Johan
author_sort Eyckmans, Tom
collection PubMed
description
format Online
Article
Text
id pubmed-4012818
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-40128182014-05-09 Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013 Eyckmans, Tom Wollants, Elke Janssens, Ann Schoemans, Hélène Lagrou, Katrien Wauters, Joost Maertens, Johan Emerg Infect Dis Letters to the Editor Centers for Disease Control and Prevention 2014-05 /pmc/articles/PMC4012818/ /pubmed/24751368 http://dx.doi.org/10.3201/eid2005.131766 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Letters to the Editor
Eyckmans, Tom
Wollants, Elke
Janssens, Ann
Schoemans, Hélène
Lagrou, Katrien
Wauters, Joost
Maertens, Johan
Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title_full Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title_fullStr Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title_full_unstemmed Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title_short Coxsackievirus A16 Encephalitis during Obinutuzumab Therapy, Belgium, 2013
title_sort coxsackievirus a16 encephalitis during obinutuzumab therapy, belgium, 2013
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4012818/
https://www.ncbi.nlm.nih.gov/pubmed/24751368
http://dx.doi.org/10.3201/eid2005.131766
work_keys_str_mv AT eyckmanstom coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT wollantselke coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT janssensann coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT schoemanshelene coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT lagroukatrien coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT wautersjoost coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013
AT maertensjohan coxsackievirusa16encephalitisduringobinutuzumabtherapybelgium2013

Ejemplares similares